Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
50 studies found for:    "Pars planitis"
Show Display Options
Rank Status Study
21 Recruiting Study of the Effectiveness of Ozurdex for the Control of Uveitis
Conditions: Uveitis, Intermediate;   Uveitis, Posterior
Intervention: Drug: Dexamethasone pellet
22 Completed Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema
Conditions: Uveitis;   Glaucoma
Intervention:
23 Not yet recruiting Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Conditions: Uveitis;   Uveitis, Posterior;   Uveitis, Anterior;   Uveitis, Intermediate;   Panuveitis
Intervention:
24 Completed A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate;   Panuveitis
Interventions: Drug: Placebo;   Drug: LX211
25 Completed A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate;   Panuveitis
Interventions: Drug: Placebo;   Drug: LX211
26 Recruiting Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis
Conditions: Uveitis;   Uveitis, Posterior;   Uveitis, Anterior;   Uveitis, Intermediate;   Panuveitis
Interventions: Drug: 4mg CLS-TA Suprachoriodal Injection;   Drug: Sham Procedure
27 Completed Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
Conditions: Uveitis;   Macular Edema;   Uveitis, Posterior;   Uveitis, Anterior;   Panuveitis;   Uveitis, Intermediate
Interventions: Drug: 4 mg CLS-TA;   Drug: 0.8 mg CLS-TA
28 Recruiting Ustekinumab (STELARA ) for the Treatment of Active Sight-Threatening Uveitis
Condition: Uveitis
Intervention: Drug: Ustekinumab
29 Recruiting Immunogenetic Mechanisms in Behcet's Disease
Conditions: Behcet's Disease;   Uveitis
Intervention:
30 Completed
Has Results
Multicenter Uveitis Steroid Treatment (MUST) Trial
Condition: Uveitis
Interventions: Drug: fluocinolone acetonide intraocular implant;   Drug: oral corticosteroid with immunosuppressive agents as needed
31 Completed Vascular Endothelial Growth Factor (VEGF) in Uveitis
Conditions: Macular Edema, Cystoid;   Uveitis
Intervention:
32 Enrolling by invitation The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
Conditions: Uveitis;   Vasculitis;   Ocular Inflammatory Disease
Intervention:
33 Completed
Has Results
Topical Interferon Gamma for Macular Edema Secondary to Uveitis
Conditions: Anterior Uveitis;   Uveitis
Intervention: Drug: Interferon Gamma-1b
34 Withdrawn Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis
Condition: Uveitis
Intervention: Biological: AIN457
35 Terminated Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis
Condition: Uveitis
Interventions: Biological: AIN457;   Biological: Placebo
36 Terminated
Has Results
Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis
Condition: Uveitis
Interventions: Drug: AIN457;   Drug: Placebo
37 Terminated
Has Results
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
Condition: Non-infectious Uveitis
Interventions: Biological: AIN457;   Drug: Placebo
38 Completed
Has Results
Phase III Study in Refractory Behcet's Disease
Condition: Behcet Disease
Interventions: Drug: AIN457;   Drug: Placebo
39 Completed The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma
Condition: Uveitis
Intervention: Drug: Interferon Gamma 1-b
40 Terminated Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X)
Condition: Chronic Uveitis
Intervention: Biological: Gevokizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-50) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.